Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Introduction<p>Genetic polymorphisms in CYP2D6 and CYP2C19 significantly influence the metabolism, efficacy, and safety of antidepressant medications. Limited data exist on the prevalence of these actionable pharmacogenetic variants in the Central Indian population. This study aimed to determi...

詳細記述

保存先:
書誌詳細
第一著者: Santenna Chenchula (14775163) (author)
その他の著者: Atal Shubham (22679330) (author), Rozatkar Abhijit (22679333) (author), Tamonud Modak (22679336) (author), Kohat Komal (22679339) (author), Ratinder Jhaj (22679342) (author), Singh Jitendra (22679345) (author), Satyaprakash V. (22679348) (author), Sadasivam Balakrishnan (22679351) (author)
出版事項: 2025
主題:
Pharmacology
pharmacogenetics
CYP2D6
CYP2C19
antidepressants
common mental disorders
indian population
copy number variation
CPIC
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
このレコードへの初めてのコメントを付けませんか!
この操作にはログインが必要です

類似資料